BAKER BROS ADVISORS LLC Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 14,658,102 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 14,658,102 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 1,399,516 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,399,516 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 7,018,874 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,284,771 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 734,518 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 313,621 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 3,734,103 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 3,734,103 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 420,897 | 0 | 420,897 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 420,897 | 0 | 0 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 3,734,103 | 0 | 3,734,103 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 420,897 | 0 | 420,897 | |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 18.00 | 2,700,597 | 48,610,746 | 2,700,597 | 0 to 2.7 M |
May 31 2018 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 18.00 | 299,403 | 5,389,254 | 299,403 | 0 to 299.4 K |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 56.77 | 9,260 | 525,690 | 9,260 | |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 45,829,686 | 45.8 M to 45.8 M (+0.01 %) |
May 18 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 56.77 | 3,700 | 210,049 | 5,291,874 | 5.3 M to 5.3 M (+0.07 %) |
May 11 2018 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,174 | 0 | 7,648,080 | 7.6 M to 7.6 M (+0.03 %) |
May 11 2018 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 2,174 | 0 | 982,320 | 980.1 K to 982.3 K (+0.22 %) |
May 09 2018 | AQXP | AQUINOX PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 13.10 | 30,000 | 393,000 | 30,000 | |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.02 | 126,399 | 6,828,339 | 45,825,986 | 45.7 M to 45.8 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 53.70 | 129,715 | 6,966,305 | 45,699,587 | 45.6 M to 45.7 M (+0.28 %) |
May 08 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.68 | 204,537 | 10,775,582 | 45,569,872 | 45.4 M to 45.6 M (+0.45 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.08 | 10,000 | 100,800 | 0 | |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 54.42 | 9,105 | 495,488 | 45,365,335 | 45.4 M to 45.4 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.26 | 21,442 | 1,120,576 | 45,356,230 | 45.3 M to 45.4 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 37,400 | 1,957,022 | 45,334,788 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.88 | 2,000 | 103,750 | 45,297,388 | 45.3 M to 45.3 M (0.00 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.33 | 5,951 | 311,418 | 45,295,388 | 45.3 M to 45.3 M (+0.01 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 52.06 | 37,963 | 1,976,213 | 45,289,437 | 45.3 M to 45.3 M (+0.08 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.37 | 57,270 | 2,941,708 | 45,251,474 | 45.2 M to 45.3 M (+0.13 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.36 | 10,500 | 539,280 | 45,194,204 | 45.2 M to 45.2 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.30 | 22,700 | 1,164,424 | 45,183,704 | 45.2 M to 45.2 M (+0.05 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.26 | 72,533 | 3,717,693 | 45,161,004 | 45.1 M to 45.2 M (+0.16 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.14 | 100,000 | 5,114,000 | 45,088,471 | 45 M to 45.1 M (+0.22 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 44,988,471 | 45 M to 45 M (+0.02 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.08 | 10,000 | 100,800 | 5,288,174 | 5.3 M to 5.3 M (+0.19 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.25 | 168,097 | 8,614,786 | 44,978,471 | 44.8 M to 45 M (+0.38 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.07 | 52,700 | 2,691,173 | 44,810,374 | 44.8 M to 44.8 M (+0.12 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 51.03 | 248,121 | 12,661,069 | 44,757,674 | 44.5 M to 44.8 M (+0.56 %) |
May 02 2018 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 50.90 | 154,218 | 7,849,897 | 44,509,553 | 44.4 M to 44.5 M (+0.35 %) |